Does chronic infection in retroviruses have a sense?

Trends in Microbiology

Volumn 23, Issue 6, 2015, Pages 367-375

  Barbeau, Benoit ^a   Mesnard, Jean Michel ^b  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b University of Montpellier I and II   (France)

Author keywords

Antisense transcription; ASP; Chronic infection; HBZ; HIV 1; HTLV

Indexed keywords

ANTISENSE PROTEIN; HBZ PROTEIN; INTERLEUKIN 2; TAX PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; HBZ PROTEIN, HUMAN T-CELL LEUKEMIA VIRUS TYPE I; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; VIRAL PROTEIN;

AUTOPHAGY; DENDRITIC CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; LONG TERMINAL REPEAT; LYMPHOCYTE PROLIFERATION; MACROPHAGE; NONHUMAN; OPEN READING FRAME; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RETROVIRUS INFECTION; REVIEW; VIRION; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CHRONIC DISEASE; GENETIC TRANSCRIPTION; GENETICS; HTLV-1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHYSIOLOGY; PROMOTER REGION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHRONIC DISEASE; HIV INFECTIONS; HIV-1; HTLV-I INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PROMOTER REGIONS, GENETIC; RETROVIRIDAE PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84930929352     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2015.01.009     Document Type: Review

References (91)

1. Klatt N.R., et al. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol. Rev. 2013, 254:326-342.
2. Iwanaga M., et al. Adult T-cell leukemia: a review of epidemiological evidence. Front. Microbiol. 2012, 3:322.
3. Yasunaga J., Matsuoka M. Molecular mechanisms of HTLV-1 infection and pathogenesis. Int. J. Hematol. 2011, 94:435-442.
4. Bunn P.A., et al. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N. Engl. J. Med. 1983, 309:257-264.
5. Barbeau B., et al. Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis. Front. Microbiol. 2013, 4:226.
6. Larocca D., et al. Human T-cell leukemia virus minus strand transcription in infected T-cells. Biochem. Biophys. Res. Commun. 1989, 163:1006-1013.
7. Miller R.H. Human immunodeficiency virus may encode a novel protein on the genomic DNA plus strand. Science 1988, 239:1420-1422.
8. Michael N.L., et al. Naturally occuring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and tat-induced transcriptional activities. J. Virol. 1994, 68:3163-3174.
9. Wei W., et al. Functional consequences of bidirectional promoters. Trends Genet. 2011, 27:267-276.
10. Gaudray G., et al. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 2002, 76:12813-12822.
11. Cavanagh M.H., et al. HTLV-I antisense transcripts initiating in the 3' LTR are alternatively spliced and polyadenylated. Retrovirology 2006, 3:15.
12. Murata K., et al. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J. Virol. 2006, 80:2495-2505.
13. Satou Y., et al. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:720-725.
14. Halin M., et al. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood 2009, 114:2427-2438.
15. Larocque E., et al. Human T-cell lymphotropic virus type 3 (HTLV-3)- and HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization. J. Virol. 2011, 85:12673-12685.
16. Basbous J., et al. The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J. Biol. Chem. 2003, 278:43620-43627.
17. Hivin P., et al. A modified version of a Fos-associated cluster in HBZ affects Jun transcriptional potency. Nucleic Acids Res. 2006, 34:2761-2772.
18. Matsumoto J., et al. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene 2005, 24:1001-10
19. Thebault S., et al. HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett. 2004, 562:165-170.
20. Kuhlmann A.S., et al. HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology 2007, 4:92.
21. Shaulian E. AP-1 - the Jun proteins: oncogenes or tumor suppressors in disguise?. Cell. Signal. 2010, 22:894-899.
22. Zhao T., et al. Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-κB. Blood 2009, 113:2755-2764.
23. Hagiya K., et al. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology 2011, 8:19.
24. Reinke A.W., et al. Identification of bZIP interaction partners of viral proteins HBZ, MEQ, BZLF1, and K-bZIP using coiled-coil arrays. Biochemistry 2010, 49:1985-1997.
25. Zhao T., et al. HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator. Blood 2011, 118:1865-1876.
26. Clerc I., et al. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of Tax-dependent viral transcription by HBZ. J. Biol. Chem. 2008, 283:23903-23913.
27. Ohshima T., et al. HTLV-1 basic leucine-zipper factor, HBZ, interacts with MafB and suppresses transcription through a Maf recognition element. J. Cell. Biochem. 2010, 111:187-194.
28. Mukai R., Ohshima T. Dual effects of HTLV-1 bZIP factor in suppression of interferon regulatory factor 1. Biochem. Biophys. Res. Commun. 2011, 409:328-332.
29. Satou Y., et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011, 7:e1001274.
30. Sugata K., et al. HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines. Blood 2012, 119:434-444.
31. Lemasson I., et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J. Virol. 2007, 81:1543-1553.
32. Tanaka-Nakanishi A., et al. HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization. Cancer Res. 2014, 74:188-200.
33. Matsuoka M., Yasunaga J. Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor. Curr. Opin. Virol. 2013, 3:684-691.
34. Wurm T., et al. The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP. Nucleic Acids Res. 2012, 40:5910-5925.
35. Zhao T., et al. HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling. Retrovirology 2013, 10:159.
36. Ma G., et al. HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells. Oncogene 2013, 32:4222-4230.
37. Philip S., et al. Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex. PLoS Pathog. 2014, 10:e1004040.
38. Miyazaki M., et al. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis. J. Virol. 2007, 81:5714-5723.
39. Arnold J., et al. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008, 112:3788-3797.
40. Zhao T., et al. Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice. Arch. Virol. 2014, 159:1849-1856.
41. Gazon H., et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3' long terminal repeat. J. Virol. 2012, 86:9070-9078.
42. Borowiak M., et al. HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene. Carcinogenesis 2013, 34:2664-2672.
43. Vernin C., et al. HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs. Cancer Res. 2014, 74:6082-6093.
44. + T cells. J. Clin. Invest. 2014, 124:3431-3442.
45. + T-lymphocyte responses that correlate with clinical outcome. J. Infect. Dis. 2011, 203:529-536.
46. Enose-Akahata Y., et al. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals. Retrovirology 2013, 10:19.
47. Narita T., et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J. Immunol. 2014, 192:940-947.
48. Yamamoto-Taguchi N., et al. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog. 2013, 9:e1003630.
49. + T cells in virus-infected individuals. Retrovirology 2012, 9:46.
50. Bartman M.T., et al. Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood 2008, 112:3995-4002.
51. Marban C., et al. Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway. Retrovirology 2012, 9:98.
52. Yin H., et al. Human T-cell leukemia virus type 2 antisense viral protein 2 is dispensable for in vitro immortalization but functions to repress early virus replication in vivo. J. Virol. 2012, 86:8412-8421.
53. Douceron E., et al. HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis. J. Infect. Dis. 2012, 205:82-86.
54. Larocque E., et al. Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif. J. Virol. 2014, 88:8956-8970.
55. Landry S., et al. Detection, characterization and regulation of antisense transcripts in HIV-1. Retrovirology 2007, 4:71.
56. Schopman N.C., et al. Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res. 2012, 40:414-427.
57. Kobayashi-Ishihara M., et al. HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period. Retrovirology 2012, 9:38.
58. Saayman S., et al. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Mol. Ther. 2014, 22:1164-1175.
59. Lefebvre G., et al. Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J. Virol. 2011, 85:6205-6211.
60. Barbagallo M.S., et al. Potential control of human immunodeficiency virus type 1 asp expression by alternative splicing in the upstream untranslated region. DNA Cell Biol. 2012, 31:1303-1313.
61. Briquet S., Vaquero C. Immunolocalization studies of an antisense protein in HIV-1-infected cells and viral particles. Virology 2002, 292:177-184.
62. Laverdure S., et al. HIV-1 antisense transcription is preferentially activated in primary monocyte-derived cells. J. Virol. 2012, 86:13785-13789.
63. Clerc I., et al. Polarized expression of the membrane ASP protein derived from HIV-1 antisense transcription in T cells. Retrovirology 2011, 8:74.
64. + individuals. Virology 1995, 206:196-202.
65. Bansal A., et al. CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription. J. Exp. Med. 2010, 207:51-59.
66. Ludwig L.B., et al. Human immunodeficiency virus-type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology 2006, 3:80.
67. Torresilla C., et al. Detection of the HIV-1 minus-strand-encoded antisense protein and its association with autophagy. J. Virol. 2013, 87:5089-5105.
68. Kruse M., et al. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 2000, 74:7127-7136.
69. + T cells. J. Exp. Med. 1997, 186:801-812.
70. Engelmayer J., et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 1999, 163:6762-6768.
71. Arpin-Andre C., et al. Construction of a reporter vector for analysis of bidirectional transcriptional activity of retrovirus LTR. Plasmid 2014, 74:45-51.
72. Prescott E.M., Proudfoot N.J. Transcriptional collision between convergent genes in budding yeast. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8796-8801.
73. Yoshida M., et al. Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. J. Virol. 2008, 82:9359-9368.
74. Sarkis S., et al. Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression. J. Clin. Virol. 2013, 58:295-298.
75. Belrose G., et al. Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes. Blood 2011, 118:2483-2491.
76. Barbeau B., Mesnard J.M. Making sense out of antisense transcription in human T-cell lymphotropic viruses (HTLVs). Viruses 2011, 3:456-468.
77. Li M., et al. Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J. Virol. 2009, 83:3788-3797.
78. Yang Z., Klionsky D.J. Eaten alive: a history of macroautophagy. Nat. Cell Biol. 2010, 12:814-822.
79. Tooze S.A., Yoshimori T. The origin of the autophagosomal membrane. Nat. Cell Biol. 2010, 12:831-835.
80. Wirawan E., et al. Autophagy: for better or for worse. Cell Res. 2012, 22:43-61.
81. Farre J.C., Subramani S. Rallying the exocyst as an autophagy scaffold. Cell 2011, 144:172-174.
82. Bodemann B.O., et al. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 2011, 144:253-267.
83. Matsunaga K., et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat. Cell Biol. 2009, 11:385-396.
84. Dreux M., Chisari F.V. Viruses and the autophagy machinery. Cell Cycle 2010, 9:1295-1307.
85. Tang S.W., et al. Impact of cellular autophagy on viruses: insights from hepatitis B virus and human retroviruses. J. Biomed. Sci. 2012, 19:92.
86. Dong X., Levine B. Autophagy and viruses: adversaries or allies?. J. Innate Immun. 2013, 5:480-493.
87. Dinkins C., et al. Autophagy, HIV. Semin. Cell Dev. Biol. 2010, 21:712-718.
88. Killian M.S. Dual role of autophagy in HIV-1 replication and pathogenesis. AIDS Res. Ther. 2012, 9:16.
89. Espert L., et al. Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J. Clin. Invest. 2006, 116:2161-2172.
90. Espert L., et al. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS ONE 2009, 4:e5787.
91. Kyei G.B., et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 2009, 186:255-268.